These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2016248)

  • 21. Is buspirone effective for panic disorder?
    Sheehan DV; Raj AB; Sheehan KH; Soto S
    J Clin Psychopharmacol; 1990 Feb; 10(1):3-11. PubMed ID: 2407755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buspirone: multicenter efficacy study.
    Wheatley D
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):92-4. PubMed ID: 6130079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of the anxiolytic effects of buspirone in high- and low-anxious normal humans assessed by frontal midline theta activity.
    Mizuki Y; Suetsugi M; Ushijima I; Yamada M
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):291-300. PubMed ID: 7519702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind, controlled trial in primary care patients with generalized anxiety: a comparison between buspirone and oxazepam.
    Strand M; Hetta J; Rosen A; Sörensen S; Malmström R; Fabian C; Marits K; Vetterskog K; Liljestrand AG; Hegen C
    J Clin Psychiatry; 1990 Sep; 51 Suppl():40-5. PubMed ID: 2211567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Switching from benzodiazepines to buspirone using a tapered overlap method in generalized anxiety disorder.
    Arató M
    J Clin Psychiatry; 2001 Aug; 62(8):657-8. PubMed ID: 11561943
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of social factors on the anxiolytic efficacy of buspirone in male rats, male mice, and men.
    Majercsik E; Haller J; Leveleki C; Baranyi J; Halász J; Rodgers RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Dec; 27(8):1187-99. PubMed ID: 14659474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The side effect profile of buspirone in comparison to active controls and placebo.
    Newton RE; Casten GP; Alms DR; Benes CO; Marunycz JD
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):100-2. PubMed ID: 6130065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eltoprazine in aggressive mentally handicapped patients: a double-blind, placebo- and baseline-controlled multi-centre study. The Eltoprazine Aggression Research Group.
    de Koning P; Mak M; de Vries MH; Allsopp LF; Stevens RB; Verbruggen R; Van den Borre R; van Peteghem P; Kohen D; Arumainayagam M
    Int Clin Psychopharmacol; 1994 Sep; 9(3):187-94. PubMed ID: 7814828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and CNS pharmacodynamics of the 5-HT1A agonist buspirone in humans following acute L-tryptophan depletion challenge.
    Jagannathan V; Venitz J
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):351-62. PubMed ID: 9379784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Azaspirodecanediones in generalized anxiety disorder: buspirone.
    Ortiz A; Pohl R; Gershon S
    J Affect Disord; 1987; 13(2):131-43. PubMed ID: 2960708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buspirone in depressed outpatients: a controlled study.
    Rickels K; Amsterdam J; Clary C; Hassman J; London J; Puzzuoli G; Schweizer E
    Psychopharmacol Bull; 1990; 26(2):163-7. PubMed ID: 2236452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical effects of buspirone on intractable self-injury in adults with mental retardation.
    Ricketts RW; Goza AB; Ellis CR; Singh YN; Chambers S; Singh NN; Cooke JC
    J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(2):270-6. PubMed ID: 8150800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Buspirone: a new possibility in the treatment of anxiety].
    Faludi G
    Orv Hetil; 1994 Aug; 135(33):1807-13. PubMed ID: 8072756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term anxiolytic therapy: the issue of drug withdrawal.
    Lader M
    J Clin Psychiatry; 1987 Dec; 48 Suppl():12-6. PubMed ID: 2891684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of buspirone on normal and hypoarousal-driven abnormal aggression in rats.
    Haller J; Horváth Z; Bakos N
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):27-31. PubMed ID: 16893596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buspirone: a worldwide update.
    Napoliello MJ; Domantay AG
    Br J Psychiatry Suppl; 1991 Sep; (12):40-4. PubMed ID: 1840762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for treatment of generalized anxiety in the primary care setting.
    Schweizer E; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 3():27-31; discussion 32-3. PubMed ID: 9133490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can buspirone substitute for benzodiazepines in all anxious patients?
    Wang RI; Tiuseco D; Roh BL; Cho JK; Kochar C
    NIDA Res Monogr; 1989; 95():433-4. PubMed ID: 2577045
    [No Abstract]   [Full Text] [Related]  

  • 40. Paramenstrual aggression in mentally retarded adult ameliorated by buspirone.
    Colella RF; Ratey JJ; Glaser AI
    Int J Psychiatry Med; 1992; 22(4):351-6. PubMed ID: 1293064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.